Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease

Annals of Clinical Biochemistry

Volumn 42, Issue 5, 2005, Pages 387-393

  Reuter, Stephanie E ^a   Evans, Allan M ^a   Faull, Randall J ^b   Chace, Donald H ^c   Fornasini, Gianfranco ^d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c PERKINELMER INC   (United States)

^d Sigma Tau Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARBON;

ADULT; AGED; BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARNITINE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 25144483298     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563054889954     Document Type: Conference Paper

References (24)

1. Bremer J. Carnitine - metabolism and functions. Physiol Rev 1983; 63: 1420-80
2. Engel AG, Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 1973; 179: 899-902
3. Bieber LL. Carnitine. Annu Rev Biochem 1988; 57: 261-83
4. Evans AM. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003; 41: S13-26
5. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003; 42: 941-67
6. Brass EP. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin Ther 1995; 17: 176-85
7. Bartel LL, Hussey JL, Shrago E. Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 1981; 34: 1314-20
8. Guarnieri G, Toigo G, Crapesi L, et al. Carnitine metabolism in chronic renal failure. Kidney Int 1987; 22: S116-27
9. Rodriguez-Segade S, Alonso de la Pena C, Paz M, et al. Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency. Ann Clin Biochem 1986; 23: 671-5
10. Wanner C, Förstner-Wanner S, Rössle C, Fürst P, Schollmeyer P, Hörl WH. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation. Kidney Int 1987; 32: S132-5
11. Rodriguez-Segade S, Alonso de la Pena C, Paz JM, et al. Carnitine deficiency in haemodialysed patients. Clin Chim Acta 1986; 159: 249-66
12. Ahmad S. Carnitine, kidney and renal dialysis. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and its Role in Medicine: From Function to Therapy. New York, USA: Academic Press, 1992; 381-400
13. Bellinghieri G, Savica V, Mallamace A, et al. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38: 523-31
14. Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; 1: 126-8
15. Evans AM, Faull R, Fornasini G, et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 2000; 68: 238-49
16. Golper TA, Wolfson M, Ahmad S, et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 1990; 38: 904-11
17. Penn D, Schmidt-Sommerfeld E. Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis. Metabolism 1983; 32: 806-9
18. Savica V, Bellinghieri G, Di Stefano C, et al. Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 1983; 35: 232-6
19. Wanner C, Förstner-Wanner S, Schaeffer G, Schollmeyer P, Hörl WH. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 1986; 6: 206-11
20. Wanner C, Hörl WH. Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. Nephron 1988; 50: 89-102
21. Evans AM, Faull RJ, Nation RL, et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 2004; 66: 1527-34
22. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47: 1166-82
23. Longo A, Bruno G, Curti S, Mancinelli A, Miotto G. Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatisation with 1-aminoanthracene. J Chromatogr B Biomed Appl 1996; 686: 129-39
24. 2+ efflux from the sarcoplasmic reticulum. J Cardiovasc Pharmacol 2000; 36: 14-21